Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT05711888
Recruiting Not applicable

Semantic Recognition Task (SRT) in Alzheimer Disease

NCT05711888 · tracked via the Priya Life Science Turkey tracker
Sponsor
Istanbul University
Phase
Not applicable
Started
2022-12-21
Last updated
2024-10-02

Condition(s) studied

Alzheimer Disease

Investigational drug(s) / intervention(s)

Semantic Recognition Procedure

Semantic Recognition Procedure: A semantic recognition task is going to be added to administrated FCSRT procedure after immediate and delayed recall phases.

Study summary

The goal of this study is to observe the outcomes of a semantic recognition task in Alzheimer Disease and discuss what this might add to clinical practice.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * to have biomarker analysis for Alzheimer disease (positive or negative). Exclusion Criteria: * illiteracy

Primary outcome measure(s)

  • Semantic Recognition Task — 1 day
    The number of correct answers will be observed just after the short-term learning procedure and just after the delayed recall procedure among people with positive biomarker compared to those with negative biomarker to Alzheimer Disease.

Trial sites (1)

FacilityCityRegionStatus
Jbid Dursun Uncu Beşiktaş Istanbul Recruiting

More Istanbul University trials in Turkey

Complementary Feeding Education & Fathers Recruiting
Sentinel Lymph Node (SLN) Mapping with Charcoal Carbon Dye in Early Stage Cervical Cancer Active, not recruiting
Two-Year Follow-up Study on Children Exposed to Trauma Active, not recruiting
The Effectiveness of Dextrose Prolotherapy in Patients With Coccydynia Recruiting
Efficacy of Video-Based Interactive Game Therapy in Interstitial Lung Patients Recruiting

Other trials for the same condition

Effect of Art Therapy on Cognitive and Hand Functions of Alzheimer's Patients Starting soon
The Effects of Specific tDCS on Cognition in MCI Recruiting
Prediction of Effectiveness of rTMS Application in Alzheimer's Patients Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) Recruiting
Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05711888 on ClinicalTrials.gov ↗ ← All trials in Turkey